American Society of Hematology

Table 1.

ORR and PFS for patients with the 17p deletion or F-refractory CLL after different treatment approaches

$ORR and PFS for patients with the 17p deletion or F-refractory CLL after different treatment approaches$

^#Data shown are only for patients with F-refractory CLL.